The third case involved an infant with an ambiguous genetic profile and near-normal CFTR function who remained symptom-free and was ultimately classified as a CF carrier, suggesting that PDIO assays could help discontinue unnecessary follow-up. The gene discussed is CFTR; the disease is cystic fibrosis.